RS41271951 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Cathepsin S levels | A | OR: 0.68 | 4E-204 | PubMed |
| Cathepsin S levels | G | OR: 1.21 | 3E-152 | PubMed |
| Serum levels of protein CTSS | G | OR: 0.77 | 7E-120 | PubMed |
| Cathepsin S levels (CTSS.3181.50.2) | G | OR: 0.86 | 7E-94 | PubMed |
| Cathepsin S levels | G | OR: 0.88 | 7E-43 | PubMed |
| Cathepsin S levels | — | OR: 1.17 | 2E-42 | PubMed |
| ACVRL1/SCARB2 protein level ratio | — | OR: 0.16 | 3E-42 | PubMed |
| Cathepsin S levels | G | OR: 0.96 | 4E-40 | PubMed |
| MSR1 protein levels | G | β: 0.094 | 1E-26 | PubMed |
| Creatinine levels | G | β: 0.043 | 7E-23 | PubMed |
| Estimated glomerular filtration rate | G | β: 0.042 | 7E-22 | PubMed |
| Apolipoprotein A1 levels | G | β: 0.041 | 2E-19 | PubMed |
| Calcium levels | G | β: 0.04 | 1E-18 | PubMed |
| DEFA1 or DEFA1B protein levels | G | β: 0.081 | 8E-18 | PubMed |
| Glycated hemoglobin levels | G | β: 0.038 | 2E-17 | PubMed |
| Basal cell carcinoma | G | OR: 1.11 | 4E-17 | PubMed |
| Basal cell carcinoma | G | OR: 1.11 | 8E-17 | PubMed |
| High density lipoprotein cholesterol levels | G | β: 0.036 | 4E-15 | PubMed |
| Basal cell carcinoma | G | OR: 1.12 | 1E-14 | PubMed |
| Calcium (mean, inv-norm transformed) | A | β: 0.047 | 4E-14 | PubMed |